ArticleMedical physics2026
Dual-branch MRI denoising and motion artifact suppression with uncertainty estimation and segmentation-based evaluation.
Article in Medical physics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundMagnetic resonance (MR) images are essential for clinical diagnosis, yet their quality is often compromised by noise and motion artifacts, potentially obscuring anatomical details and reducing diagnostic accuracy. Existing deep learning approaches frequently address denoising and motion artifact suppression as separate tasks, overlook pixel correlations and varying noise levels, require manual parameter tuning, and lack uncertainty evaluation, thus limiting their practical utility in clinical settings. PURPOSE: This study aims to develop a Dual-branch MRI Denoising and Motion Artifact Suppression with Uncertainty Estimation and Segmentation-based Evaluation (DbUSNet). The model is designed to adaptively handle varying noise and motion artifact levels, preserve complex structural details, and provide uncertainty estimates for the processed outputs. This may offer insights into downstream clinical tasks such as image segmentation.
methodsThe DbUSNet integrates two specialized branches: A Heterogeneous Window Transformer Network (HWTNet) for adaptive denoising using both local and global feature modeling, and an improved U-Net based Motion Artifact Suppression Network (ASNet). Each branch is coupled with an estimation subnetwork-Noise Estimation Subnetwork (NES) and Artifact Estimation Subnetwork (AES)-to dynamically assess and adapt to input specific degradation levels. The outputs of both branches are fused via an attention-based fusion module. Uncertainty is quantified during inference using Monte Carlo (MC) dropout. The model was trained and tested on brain MR scans from Brats2021 dataset (2000 samples), OpenNeuro dataset (22 samples), and MR-ART dataset (148 samples), incorporating synthetic Rician noise and motion artifacts. Downstream segmentation performance was evaluated on the Medical Segmentation Decathlon (MSD) brain dataset (1666 samples) and a prostate MR dataset (203 samples).
resultsOn the Brats2021, OpenNeuro, and MR-ART testsets, DbUSNet achieved PSNR of 28.23 dB, 27.13 dB, and 27.83 dB, SSIM of 0.93, 0.91, and 0.92, NMSE of 0.08, 0.08, and 0.08, respectively. For the downstream segmentation task, the denoised and motion artifact suppressed outputs led to average Dice score improvements of 3.10%, 3.59%, 2.46%, and 2.15% for T1, T1ce, FLAIR, and T2 modalities in the MSD brain dataset, and 2.16% and 2.24% for T2 and ADC sequences in the prostate dataset.
conclusionThe DbUSNet framework jointly performs adaptive denoising and motion artifact suppression within a unified pipeline and enables pixel-wise uncertainty quantification. Evaluations on controlled brain MRI datasets show consistent image quality gains and improved downstream segmentation performance, though the limited size and healthy-only composition of real motion test cohorts restrict wide clinical extrapolation. This work delivers a feasible technical prototype for MR image enhancement; larger, diverse clinical patient datasets will be required to further validate its clinical utility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.